The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 314.50
Bid: 316.00
Ask: 317.00
Change: -0.50 (-0.16%)
Spread: 1.00 (0.316%)
Open: 314.50
High: 318.50
Low: 314.50
Prev. Close: 315.00
MGAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

24 Mar 2011 17:10

RNS Number : 6006D
Morgan Crucible Co PLC
24 March 2011
 



Notification of interests of directors/persons discharging managerial responsibility and connected persons ("PDMRs")

24th March 2011

This notification is made pursuant to DTR 3.1.4R (1)(a).

The Company announces that on 23rd March 2011 awards over ordinary 25p shares in the Company were made to the Directors and PDMRs listed below under the Company's Long Term Incentive Plan 2004 ("LTIP"). Subject to satisfaction of performance targets, awards under the LTIP will vest in three years' time. Except as described below in relation to Kevin Dangerfield and Peter Blausten (who have capacity within the £30,000 limit described below) the awards are structured as conditional awards of free shares.

Kevin Dangerfield and Peter Blausten each received an award structured as an Approved Performance Share Plan ("APSP") award. APSP awards under the LTIP comprise three elements: (i) an HM Revenue & Customs approved option over shares to the value of the first £30,000 worth of the award with an exercise price of 292.28 pence per share; (ii) an LTIP award in the form of a conditional award of free shares to the value of the remainder of the award above this limit; and (iii) a funding award, also in the form of a conditional award of free shares, over such number of shares whose value at exercise of the approved option equals £30,000. In addition to satisfaction of the performance targets, the approved option and the associated funding award will only vest in the event that the market value of a share at vesting is greater than 292.28 pence per share. The funding award is solely used to fund the exercise price of the approved option and will be satisfied by shares from the Company's employee benefit trust. Following vesting of the funding award, these shares are retained by the trust and not delivered to the participant. 

Name

Number of shares subject to award (approved option and LTIP award)

Maximum number of shares subject to funding award (not delivered to participant)

Mark Robertshaw

171,068

Nil

Kevin Dangerfield

90,666

6,481

Andrew Hosty

102,641

Nil

Peter Blausten

47,899

10,264

Paul Boulton

34,213

Nil

Spencer Evans

25,660

Nil

Simon Halliday

30,792

Nil

Don Klas

82,113

Nil

Andrew Riley

34,213

Nil

 

Following the grant of awards detailed above, the total number of shares in respect of which awards are held by those individuals pursuant to the Company's Long Term Incentive Plan are detailed below:

Name

Total Number of Shares held pursuant to LTIP awards

Mark Robertshaw

875,302

Kevin Dangerfield

498,801

Andrew Hosty

486,768

Peter Blausten

47,899

Paul Boulton

194,265

Spencer Evans

58,493

Simon Halliday

150,831

Don Klas

466,240

Andrew Riley

166,441

 

Enquiries: Tracey Bigmore, The Morgan Crucible Company plc

 

Tel: 01753 837000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFIDVTISFIL
Date   Source Headline
1st May 20245:38 pmRNSHolding(s) in Company
24th Apr 20247:00 amRNSCapital Markets Update
5th Apr 202412:55 pmRNSAnnual Financial Report
4th Apr 20241:16 pmRNSDirector/PDMR Shareholding
27th Mar 20244:52 pmRNSDirector/PDMR Shareholding
27th Mar 20244:50 pmRNSDirector/PDMR Shareholding
27th Mar 20244:49 pmRNSDirector/PDMR Shareholding
27th Mar 20244:48 pmRNSDirector/PDMR Shareholding
14th Mar 20249:42 amRNSDirector/PDMR Shareholding
14th Mar 20249:41 amRNSDirector/PDMR Shareholding
13th Mar 202412:10 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSMorgan Advanced Materials Full Year 2023 Results
27th Dec 20237:00 amRNSDirector/PDMR Shareholding
19th Dec 20231:56 pmRNSDirector/PDMR Shareholding
18th Dec 20234:25 pmRNSBlock listing Interim Review
22nd Nov 202310:07 amRNSDirector/PDMR Shareholding
9th Nov 20237:00 amRNSQ3 Trading Update
9th Oct 20234:43 pmRNSDirector/PDMR Shareholding
26th Sep 202312:24 pmRNSDirector/PDMR Shareholding
16th Aug 202311:27 amRNSDirector/PDMR Shareholding
7th Aug 20235:24 pmRNSDirector/PDMR Shareholding
4th Aug 20237:00 amRNSHalf-Year Results for Period Ended 30 June 2023
13th Jul 20234:49 pmRNSDirector/PDMR Shareholding
5th Jul 20234:51 pmRNSDirector/PDMR Shareholding
29th Jun 20235:06 pmRNSResult of AGM
29th Jun 20237:00 amRNSH1 Trading Update
22nd Jun 202311:50 amRNSBlock listing Interim Review
31st May 20233:52 pmRNSDirector/PDMR Shareholding
26th May 20233:28 pmRNSNotice of Annual General Meeting 2023
24th May 20233:59 pmRNSDirector/PDMR Shareholding
11th May 202312:06 pmRNSDirector/PDMR Shareholding
11th May 202312:01 pmRNSDirector/PDMR Shareholding
11th May 202311:59 amRNSDirector/PDMR Shareholding
9th May 20235:59 pmRNSDirector/PDMR Shareholding
4th May 20235:28 pmRNSAnnual Report & Accounts 2022
3rd May 20235:38 pmRNSDirector/PDMR Shareholding
3rd May 20235:28 pmRNSDirector/PDMR Shareholding
28th Apr 20235:45 pmRNSInformation required by DTR 4.1
28th Apr 20237:00 amRNSFull-year results for the period ended 31 Dec 2022
13th Apr 20237:00 amRNSNotification of Full-Year Results
7th Feb 20237:00 amRNSUpdate on Trading and Cyber Security Incident
18th Jan 20237:00 amRNSAppointment of Chair Designate
10th Jan 20237:00 amRNSNotice of Cyber Security Incident
22nd Dec 202211:01 amRNSBlock listing Interim Review
16th Dec 20224:44 pmRNSHolding(s) in Company
6th Dec 20227:00 amRNSAccelerated Pension Contribution
6th Dec 20227:00 amRNSCapital Markets Event
23rd Nov 202210:01 amRNSDirector/PDMR Shareholding
15th Nov 20225:06 pmRNSDirector/PDMR Shareholding
10th Nov 20228:03 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.